化CRISPRi:通过引导RNA转移来调整动态范围
Bob Van Hove1, Lien De Wannemaeker2, Isolde Missiaen2
1Centre for Synthetic Biology, Ghent University, Coupure links 653, 9000 Ghent, Belgium; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
New biotechnology
|July 8, 2023
概括
对于动态应用,可以微调CRISPR干扰 (CRISPRi) 基因抑制. 新方法通过调节导向RNA水平来改善对基因表达的控制,增强诱导线性和动态范围.
科学领域:
- 分子生物学分子生物学
- 合成生物学 合成生物学
- 基因规则 基因规则
背景情况:
- 克里斯普尔干扰 (克里斯普尔i) 提供强大的基因抑制,但在可诱导系统中遭受泄漏的表达.
- 这种泄漏性使精确的控制变得复杂,特别是在动态代谢工程应用中.
研究的目的:
- 开发和评估提高CRISPRi系统可控性的方法.
- 改进基于CRISPRi的基因表达控制的动态范围和线性.
主要方法:
- 调节指导RNA (gRNA) 水平,通过合理设计的gRNA序列不匹配.
- 使用诱目标站点来微调低诱导水平的镇压.
- 实施反控制机制以提高诱导线性和动态范围.
主要成果:
- 设计的gRNA不匹配减弱了整体抑制.
- 诱目标网站使镇压的选择性调节成为可能.
- 反控制提高了诱导线性,扩大了动态范围,提高了恢复率.
结论:
- 通过gRNA设计和反控制,可以显著提高CRISPRi的可控性.
- 这些组合技术允许微调CRISPRi以满足特定应用和输入信号.
- 改进的CRISPRi控制为动态代谢工程和合成生物学开辟了新的途径.
相关概念视频
CRISPR and crRNAs
17.1K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.1K
RNA Editing
9.1K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.1K
RNA Splicing
56.5K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.5K
Alternative RNA Splicing
21.4K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.4K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K


